Skip to content

PolitiKit

Lobbying by Boehringer Ingelheim (Canada) Ltd.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Boehringer Ingelheim (Canada) Ltd.

Meetings this Parliament
4
With MPs
3
Since Nov 2021
4
Active registrations
1

Most recent reported meeting: Jul 15, 2026.

Registrations in effect

Consultant In effect since Mar 24, 2026

Consultant Lily Mesh of Wellington Dupont Public Affairs

Consultant lobbyists

  • Lily Mesh
  • Lily Mesh Former public office holder

    Formerly Executive Assistant, MP Nuttall, Member of Parliament, House of Commons (2018–2018)

  • Lily Mesh Former public office holder

    Formerly Executive Assistant, MP Nuttall, Member of Parliament, House of Commons (2018–2018)

  • Lily Mesh Former public office holder

    Formerly Executive Assistant, MP Nuttall, Member of Parliament, House of Commons (2018–2018)

  • Lily Mesh Former public office holder

    Formerly Executive Assistant, MP Nuttall, Member of Parliament, House of Commons (2018–2018)

Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO)

What they're lobbying on (2)
  • Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).
  • Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

Registration 943487-369725-5. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Lily Mesh · Consultant

    Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB). Read more

    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

  • Reported by Lily Mesh · Consultant

    Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB). Read more

    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

  • Reported by Lily Mesh · Consultant

    Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB). Read more

    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

  • Reported by Lily Mesh · Consultant

    • Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
    Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.